Diagnosis and management of Raynaud's phenomenon

BMJ. 2012 Feb 7;344:e289. doi: 10.1136/bmj.e289.
No abstract available

Publication types

  • Review

MeSH terms

  • Angiotensin Receptor Antagonists / therapeutic use
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Endothelin Receptor Antagonists
  • Humans
  • Raynaud Disease* / diagnosis
  • Raynaud Disease* / etiology
  • Raynaud Disease* / therapy
  • Referral and Consultation
  • Serotonin Uptake Inhibitors / therapeutic use
  • Vasodilator Agents / therapeutic use

Substances

  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Endothelin Receptor Antagonists
  • Serotonin Uptake Inhibitors
  • Vasodilator Agents